AzTrials
AzTrials

Anemia Complicating PregnancyHB PhNCT07800611

Pharmacist Led Intervention in the Management of Anemia Among Pregnant Woman

A study testing Pharmacist-led counseling on anemia management in people with Anemia Complicating Pregnancy, run by Hamdard University at 1 site in Pakistan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Anemia Complicating Pregnancy
What is being tested?
Pharmacist-led counseling on anemia management
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 sitePakistan
Study dates
10 Sep 2026to 15 Nov 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Pregnant woman
  • Hb <11g/dl
  • Having Punjab domicile-

Who cannot join

  • Patients with co-morbidities
  • Patients with Hb >11g/dl
  • Outside the Punjab domicile

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Muhammad Abubakar, PhD contact

00923237166544

mabubakar.pharmacist@gmail.com

Pakistan1 site
  • DHQ Chakwal

    Islamabad, Islamabad, 45570

    Maria Amin, Pharm D, 00923490526766, mattiullah@hotmail.com

Other trials in Pakistan

About this study

Official title: Pharmacist Led Intervention in the Management of Anemia Among Pregnant woman-a Randomized Controlled Trial

Anemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs of the body. Maternal anemia is associated with an increased risk of adverse maternal and fetal outcomes.

Despite the high prevalence of anemia among pregnant women, poor medication adherence and inadequate understanding of prescribed therapy may limit treatment effectiveness. Pharmacists can play an important role in providing medication-related education, improving patients' understanding of their treatment, identifying barriers to adherence, and promoting appropriate medication use. However, evidence on pharmacist-led educational interventions to improve medication adherence and hemoglobin levels among anemic pregnant women in Pakistan remains limited.

Read more

Therefore, this randomized controlled trial will be conducted to evaluate the effect of a structured pharmacist-led educational intervention on medication adherence and hemoglobin levels among anemic pregnant women in District Chakwal, Punjab, Pakistan.

A total of 100 eligible pregnant women diagnosed with anemia will be recruited and randomly allocated into intervention and control groups. Participants in the intervention group will receive a structured pharmacist-led educational intervention in addition to routine care, while participants in the control group will receive routine antenatal care and standard anemia management.

Medication adherence and hemoglobin levels will be assessed at baseline and after the intervention. The study will determine whether pharmacist-led educational counseling improves medication adherence and hemoglobin levels compared with routine care.

Data will be analyzed using IBM SPSS Statistics version 26. A paired-sample t-test will be used to compare changes in continuous variables, particularly hemoglobin levels, between baseline and post-intervention assessments. McNemar's test will be used to assess changes in paired categorical variables, including medication adherence where appropriate. A p-value of <0.05 will be considered statistically significant.

Being tested
Pharmacist-led counseling on anemia management
Keywords
Anemia, Pharmacist, intervention
Medical subject headings
Anemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pharmacist-led counseling on anemia managementOther

    Also called Pharmacist-Led Anemia Counseling

    Intervention Description: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up.

    Study Design: Single-arm, pre-post evaluation.

Study groups in NCT07800611
Study groupRoleWhat they receive
Pre and post evaluationOtherPharmacist-Led Anemia Counseling: Patients will receive individualized pharmacist-led counseling regarding anemia management, medication adherence, appropriate use of prescribed medicines, dietary measures, and strategies to improve quality of life. Outcomes will be assessed before the intervention and at one-month follow-up. Study Design: Single-arm, pre-post evaluation.
Receives: Other: Pharmacist-led counseling on anemia management

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in hemoglobin concentration

    Description: Change in hemoglobin (Hb) concentration from baseline to one-month follow-up, measured in g/dL using a laboratory hemoglobin test.

    Measured: Baseline and one month after the pharmacist-led counseling intervention.

  2. Change in anemia severity

    Description: Change in anemia severity from baseline to one-month follow-up, categorized according to the participant's measured hemoglobin concentration using the predefined diagnostic criteria for anemia.

    Measured: Baseline and one month after the pharmacist-led counseling intervention.

  3. Medication adherence

    Description: Change in medication adherence from baseline to one-month follow-up, assessed using the [name of your actual validated adherence scale/questionnaire].

    Measured: Time Frame: Baseline and one month after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2026
  2. Study start10 Sep 2026 (estimated)
  3. Primary completion15 Oct 2026 (estimated)
  4. Study completion15 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07800611
Sponsor's protocol ID
ERC-FoP-2023-007
Acronym
HB Ph
Status last verified
Aug 2026
First submitted
18 Aug 2026
Last updated
2 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Adje, D., et al. (2020). "Impact of pharmacists' health educational intervention on anemia in pregnancy in rural settings in Kano, Nigeria." Int. J. Pharm. Sci. Res 11: 2403-2410.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in